Special Issue "Pharmacological Treatment for Psychotic Disorders in Old Age"

Special Issue Editors

Dr. Alexandre González-Rodríguez
Website
Guest Editor
Department of Mental Health. Parc Tauli University Hospital. Autonomous University of Barcelona (UAB). Sabadell, Barcelona, Spain
Interests: psychopathology; clinical psychiatry; psychoeducation; cognitive disorders; neuroscience
Special Issues and Collections in MDPI journals
Prof. Dr. Manuel A. Franco-Martin
Website
Guest Editor
1. Department of Psychiatry and Mental Health, Rio Hortega University Hospital and Complejo Asistencial de Zamora, Spain
2. Research Biomedicine Institute of Salamanca (IBSAL), Psychosciences research Group (NEUR08), Salamanca University, Spain
Interests: psychogeriatrics; clinical psychiatry; dementia; psychoeducation; neuroscience
Special Issues and Collections in MDPI journals

Special Issue Information

Dear Colleagues,

Current research shows that elderly patients are at high risk for the development of psychotic symptoms. Several diagnostic categories can be associated with the presence of psychotic symptoms. This is the case for schizophrenia, delusional disorder, mood disorders, dementia, delirium, substance-use disorders, and other medical or neurologic conditions.

The recent literature shows that the efficacy of antipsychotic medications has been confined to the reduction of delusions and hallucinations, and to the diminishing of behavioral disturbances. Age alters the kinetics and dynamics of psychotropic medications, and drugs other than antipsychotics are being tested to treat cognitive, affective, and negative psychotic symptoms.

Knowledge of drug–drug interactions and comorbidities are of special interest for clinicians, as they contribute to higher mortality rates in older psychotic populations. The unmet needs of older patients must be assessed by a comprehensive history and accurate physical and mental health examinations. Adverse events should be checked and worked up, and polypharmacy should be avoided if possible.

This Special Issue aims to cover aspects of the pharmacological therapy of psychosis in older populations, including the treatment of schizophrenia, delusional disorder and other major disorders, dementia, delirium, and other medical conditions presenting psychotic symptoms. We invite authors to submit original articles and review articles.

Dr. Alexandre González-Rodríguez
Prof. Dr. Manuel Franco-Martin
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Environmental Research and Public Health is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2300 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • psychogeriatrics
  • psychosis
  • old age, pharmacological treatment
  • antipsychotics

Published Papers

This special issue is now open for submission.
Back to TopTop